A comparison of survivin expression in different thyroid cancer samples classified according to the TNM staging system, revealed that survivin and its splice variant survivin 2B mRNA level (P = 0.0052) in tumors staged pT3 and pT4, are much higher than in pT1 tumors. The gene discussed is BIRC5; the disease is thyroid cancer.